{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:45:26Z","timestamp":1782924326730,"version":"3.54.5"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Center for Infection Research Unit for Healthcare Associated Infections","award":["TTU 08.707"],"award-info":[{"award-number":["TTU 08.707"]}]},{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Appropriate antibiotic therapy (AAT) is associated with improved clinical outcomes, yet definitions used to assess AAT vary widely and focus predominantly on in-vitro susceptibility. This contrasts with antimicrobial stewardship (AMS) principles, which emphasize additional factors such as\u00a0infection focus, dosing, route, and treatment duration. We conducted a scoping review to describe how AAT is defined in clinical research and to examine the association between AAT definitions and patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included observational studies published between 2011 and 2021 evaluating the impact of AAT on outcomes in hospitalized adults with bacterial infections. Definitions of empiric and definite AAT were extracted and categorized according to the aspects considered. Association between definition characteristics and reported outcomes were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 288 included studies, nearly all (98.6%) provided a definition of AAT. Most definitions relied on in-vitro susceptibility alone for empiric (40.7%, 105\/258) and definite (31.7%, 13\/41) therapy. Other aspects (e.g. dosing, duration, guideline adherence) were used inconsistently and with heterogeneous operationalization. Details on AAT assessment were frequently missing for several aspects, including dosing and route of administration. Empiric AAT was associated with improved outcomes in 62.8% (125\/199), particularly for long-term and ICU mortality. However, the associations did not differ consistently by the type or complexity of AAT definition, except when minimum treatment duration was included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AAT definitions in current clinical research remain largely susceptibility-based and incompletely aligned with AMS frameworks. More standardized, multidimensional definitions that incorporate clinical, pharmacological, and stewardship criteria are needed to enable comparability across studies and to better understand the true impact of AAT on patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-026-02733-x","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T14:51:19Z","timestamp":1769871079000},"page":"1077-1091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing appropriateness of antibiotic therapy: a scoping review of definitions and their clinical implication"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8788-5488","authenticated-orcid":false,"given":"Lea A.","family":"Nikolai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4733-5890","authenticated-orcid":false,"given":"Beryl P.","family":"Gladstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8629-3484","authenticated-orcid":false,"given":"Arisa","family":"Hakariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3697-6576","authenticated-orcid":false,"given":"Marissa","family":"Rink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2010-4977","authenticated-orcid":false,"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-4634","authenticated-orcid":false,"given":"Siri","family":"G\u00f6pel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"11","key":"2733_CR1","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1128\/aac.00627-10","volume":"54","author":"M Paul","year":"2010","unstructured":"Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54(11):4851\u201363. https:\/\/doi.org\/10.1128\/aac.00627-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2733_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0795-y","volume":"19","author":"K Marquet","year":"2015","unstructured":"Marquet K, Liesenborgs A, Bergs J, Vleugels A, Claes N. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care. 2015;19(1):63. https:\/\/doi.org\/10.1186\/s13054-015-0795-y.","journal-title":"Crit Care"},{"key":"2733_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1123-5","volume":"15","author":"G Raman","year":"2015","unstructured":"Raman G, Avendano E, Berger S, Menon V. Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis. BMC Infect Dis. 2015;15:395. https:\/\/doi.org\/10.1186\/s12879-015-1123-5.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2733_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106184","volume":"56","author":"M Bassetti","year":"2020","unstructured":"Bassetti M, Rello J, Blasi F, Goossens H, Sotgiu G, Tavoschi L, et al. Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections. Int J Antimicrob Agents. 2020;56(6):106184. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106184.","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 3","key":"2733_CR5","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1093\/cid\/ciu548","volume":"59","author":"DD DePestel","year":"2014","unstructured":"DePestel DD, Eiland EH 3rd, Lusardi K, Destache CJ, Mercier RC, McDaneld PM, et al. Assessing appropriateness of antimicrobial therapy: in the eye of the interpreter. Clin Infect Dis. 2014;59(Suppl 3):S154\u201361. https:\/\/doi.org\/10.1093\/cid\/ciu548.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2733_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1086\/519283","volume":"45","author":"JC McGregor","year":"2007","unstructured":"McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise TP Jr., et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis. 2007;45(3):329\u201337. https:\/\/doi.org\/10.1086\/519283.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2733_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/apm.12951","volume":"127","author":"C Moser","year":"2019","unstructured":"Moser C, Lerche CJ, Thomsen K, Hartvig T, Schierbeck J, Jensen P, et al. Antibiotic therapy as personalized medicine \u2013 general considerations and complicating factors. APMIS. 2019;127(5):361\u201371. https:\/\/doi.org\/10.1111\/apm.12951.","journal-title":"APMIS"},{"issue":"6","key":"2733_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0596-8","volume":"18","author":"MD Zilberberg","year":"2014","unstructured":"Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18(6):596. https:\/\/doi.org\/10.1186\/s13054-014-0596-8.","journal-title":"Crit Care"},{"issue":"1","key":"2733_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/cc7136","volume":"13","author":"MJ Schwaber","year":"2009","unstructured":"Schwaber MJ, Carmeli Y. The effect of antimicrobial resistance on patient outcomes: importance of proper evaluation of appropriate therapy. Crit Care. 2009;13(1):106. https:\/\/doi.org\/10.1186\/cc7136.","journal-title":"Crit Care"},{"issue":"1","key":"2733_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/jac\/dkx341","volume":"73","author":"LD Dresser","year":"2018","unstructured":"Dresser LD, Bell CM, Steinberg M, Ferguson ND, Lapinsky S, Lazar N, et al. Use of a structured panel process to define antimicrobial prescribing appropriateness in critical care. J Antimicrob Chemother. 2018;73(1):246\u20139. https:\/\/doi.org\/10.1093\/jac\/dkx341.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2733_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/cid\/ciu747","volume":"60","author":"CM van den Bosch","year":"2015","unstructured":"van den Bosch CM, Geerlings SE, Natsch S, Prins JM, Hulscher ME. Quality indicators to measure appropriate antibiotic use in hospitalized adults. Clin Infect Dis. 2015;60(2):281\u201391. https:\/\/doi.org\/10.1093\/cid\/ciu747.","journal-title":"Clin Infect Dis"},{"key":"2733_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8020049","author":"G Hood","year":"2019","unstructured":"Hood G, Hand KS, Cramp E, Howard P, Hopkins S, Ashiru-Oredope D. Measuring appropriate antibiotic prescribing in acute hospitals: development of a national audit tool through a Delphi consensus. Antibiotics. 2019. https:\/\/doi.org\/10.3390\/antibiotics8020049.","journal-title":"Antibiotics"},{"issue":"suppl_6","key":"2733_CR13","doi-asserted-by":"publisher","first-page":"vi30","DOI":"10.1093\/jac\/dky116","volume":"73","author":"AA Monnier","year":"2018","unstructured":"Monnier AA, Schouten J, Le Mar\u00e9chal M, Tebano G, Pulcini C, StanicBenic M, et al. Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure. J Antimicrob Chemother. 2018;73(suppl_6):vi30\u20139. https:\/\/doi.org\/10.1093\/jac\/dky116.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2733_CR14","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2017.6821","volume":"9","author":"MC Kallen","year":"2017","unstructured":"Kallen MC, Prins JM. A systematic review of quality indicators for appropriate antibiotic use in hospitalized adult patients. Infect Dis Rep. 2017;9(1):6821. https:\/\/doi.org\/10.4081\/idr.2017.6821.","journal-title":"Infect Dis Rep"},{"issue":"1","key":"2733_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332. https:\/\/doi.org\/10.1080\/1364557032000119616.","journal-title":"Int J Soc Res Methodol"},{"issue":"7","key":"2733_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/m18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373. https:\/\/doi.org\/10.7326\/m18-0850.","journal-title":"Ann Intern Med"},{"key":"2733_CR17","doi-asserted-by":"publisher","unstructured":"Nikolai LA, Beryl P, G\u00f6pel S, Bitzer M, Tacconelli E. (2022) Antibiotic stewardship approaches in defining appropriateness of antibiotic therapy \u2013 a scoping review of studies targeting hospitalized adults treated for bacterial infections. https:\/\/doi.org\/10.17605\/OSF.IO\/ZYNGD. Accessed.","DOI":"10.17605\/OSF.IO\/ZYNGD"},{"key":"2733_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"2733_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"issue":"7","key":"2733_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/s1473-3099(16)00065-7","volume":"16","author":"EC Schuts","year":"2016","unstructured":"Schuts EC, Hulscher M, Mouton JW, Verduin CM, Stuart J, Overdiek H, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847\u201356. https:\/\/doi.org\/10.1016\/s1473-3099(16)00065-7.","journal-title":"Lancet Infect Dis"},{"key":"2733_CR21","volume-title":"Stata Statistical Software: Release 15","author":"StataCorp","year":"2017","unstructured":"StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC; 2017."},{"issue":"2","key":"2733_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cid\/cit688","volume":"58","author":"V Spoorenberg","year":"2014","unstructured":"Spoorenberg V, Hulscher ME, Akkermans RP, Prins JM, Geerlings SE. Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay. Clin Infect Dis. 2014;58(2):164\u20139. https:\/\/doi.org\/10.1093\/cid\/cit688.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2733_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11096-020-01005-4","volume":"42","author":"KA Al-Sunaidar","year":"2020","unstructured":"Al-Sunaidar KA, Prof Abd Aziz N, Prof Hassan Y. Appropriateness of empirical antibiotics: risk factors of adult patients with sepsis in the ICU. Int J Clin Pharm. 2020;42(2):527\u201338. https:\/\/doi.org\/10.1007\/s11096-020-01005-4.","journal-title":"Int J Clin Pharm"},{"issue":"11","key":"2733_CR24","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.cmi.2020.01.037","volume":"26","author":"H Seok","year":"2020","unstructured":"Seok H, Song J, Jeon JH, Choi HK, Choi WS, Moon S, et al. Timing of antibiotics in septic patients: a prospective cohort study. Clin Microbiol Infect. 2020;26(11):1495\u2013500. https:\/\/doi.org\/10.1016\/j.cmi.2020.01.037.","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"2733_CR25","doi-asserted-by":"publisher","first-page":"S174","DOI":"10.1093\/infdis\/jiz559","volume":"221","author":"T Xiao","year":"2020","unstructured":"Xiao T, Zhu Y, Zhang S, Wang Y, Shen P, Zhou Y, et al. A retrospective analysis of risk factors and outcomes of Carbapenem-Resistant Klebsiella pneumoniae bacteremia in nontransplant patients. J Infect Dis. 2020;221(Suppl 2):S174\u201383. https:\/\/doi.org\/10.1093\/infdis\/jiz559.","journal-title":"J Infect Dis"},{"issue":"2","key":"2733_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jmii.2014.05.003","volume":"49","author":"WL Cheng","year":"2016","unstructured":"Cheng WL, Hsueh PR, Lee CC, Li CW, Li MJ, Chang CM, et al. Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: appropriateness of empirical treatment matters. J Microbiol Immunol Infect. 2016;49(2):208\u201315. https:\/\/doi.org\/10.1016\/j.jmii.2014.05.003.","journal-title":"J Microbiol Immunol Infect"},{"key":"2733_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0520-8","volume":"8","author":"Q Shi","year":"2019","unstructured":"Shi Q, Huang C, Xiao T, Wu Z, Xiao Y. A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections. Antimicrob Resist Infect Control. 2019;8:68. https:\/\/doi.org\/10.1186\/s13756-019-0520-8.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"2733_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jmii.2010.08.004","volume":"44","author":"SS Wang","year":"2011","unstructured":"Wang SS, Lee NY, Hsueh PR, Huang WH, Tsui KC, Lee HC, et al. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli or Klebsiella pneumoniae. J Microbiol Immunol Infect. 2011;44(4):282\u20138. https:\/\/doi.org\/10.1016\/j.jmii.2010.08.004.","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"2733_CR29","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1469-0691.2011.03606.x","volume":"18","author":"DC Lye","year":"2012","unstructured":"Lye DC, Earnest A, Ling ML, Lee TE, Yong HC, Fisher DA, et al. The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study. Clin Microbiol Infect. 2012;18(5):502\u20138. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03606.x.","journal-title":"Clin Microbiol Infect"},{"key":"2733_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2334-13-515","volume":"13","author":"M Willmann","year":"2013","unstructured":"Willmann M, Kuebart I, Marschal M, Schroppel K, Vogel W, Flesch I, et al. Effect of metallo-beta-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study. BMC Infect Dis. 2013;13:9. https:\/\/doi.org\/10.1186\/1471-2334-13-515.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2733_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.idh.2019.02.001","volume":"24","author":"CL Lim","year":"2019","unstructured":"Lim CL, Spelman D. Mortality impact of empirical antimicrobial therapy in\u00a0ESBL- and AmpC-producing Enterobacteriaceae bacteremia in an Australian tertiary hospital. Infect Dis Health. 2019;24(3):124\u201333. https:\/\/doi.org\/10.1016\/j.idh.2019.02.001.","journal-title":"Infect Dis Health"},{"key":"2733_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-239","volume":"12","author":"Y Jung","year":"2012","unstructured":"Jung Y, Lee MJ, Sin HY, Kim NH, Hwang JH, Park J, et al. Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea. BMC Infect Dis. 2012;12:239. https:\/\/doi.org\/10.1186\/1471-2334-12-239.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2733_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10096-012-1758-8","volume":"32","author":"C Pe\u00f1a","year":"2013","unstructured":"Pe\u00f1a C, G\u00f3mez-Zorrilla S, Oriol I, Tubau F, Dominguez MA, Pujol M, et al. Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality. Eur J Clin Microbiol Infect Dis. 2013;32(3):413\u201320. https:\/\/doi.org\/10.1007\/s10096-012-1758-8.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"2733_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10096-011-1161-x","volume":"30","author":"S Reisfeld","year":"2011","unstructured":"Reisfeld S, Paul M, Gottesman BS, Shitrit P, Leibovici L, Chowers M. The effect of empiric antibiotic therapy on mortality in debilitated patients with dementia. Eur J Clin Microbiol Infect Dis. 2011;30(6):813\u20138. https:\/\/doi.org\/10.1007\/s10096-011-1161-x.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"2733_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2899","volume":"3","author":"C Rhee","year":"2020","unstructured":"Rhee C, Kadri SS, Dekker JP, Danner RL, Chen HC, Fram D, et al. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open. 2020;3(4):e202899. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2899.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2733_CR36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/s1473-3099(15)00151-6","volume":"15","author":"Y Shindo","year":"2015","unstructured":"Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Goto Y, et al. Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study. Lancet Infect Dis. 2015;15(9):1055\u201365. https:\/\/doi.org\/10.1016\/s1473-3099(15)00151-6.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2733_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s10096-014-2299-0","volume":"34","author":"J Beuving","year":"2015","unstructured":"Beuving J, Wolffs PF, Hansen WL, Stobberingh EE, Bruggeman CA, Kessels A, et al. Impact of same-day antibiotic susceptibility testing on time to appropriate antibiotic treatment of patients with bacteraemia: a randomised controlled trial. Eur J Clin Microbiol Infect Dis. 2015;34(4):831\u20138. https:\/\/doi.org\/10.1007\/s10096-014-2299-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"2733_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4046\/trd.2019.0012","volume":"83","author":"DH Kim","year":"2020","unstructured":"Kim DH, Kim HJ, Koo HW, Bae W, Park SH, Koo HK, et al. The use of inappropriate antibiotics in patients admitted to intensive care units with nursing home-acquired pneumonia at a Korean teaching hospital. Tuberculosis Respir Dis (Seoul). 2020;83(1):81\u20138. https:\/\/doi.org\/10.4046\/trd.2019.0012.","journal-title":"Tuberculosis Respir Dis (Seoul)"},{"issue":"2","key":"2733_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/shk.0000000000001599","volume":"55","author":"GT Yiang","year":"2021","unstructured":"Yiang GT, Tzeng IS, Shui HA, Wu MY, Peng MY, Chan CY, et al. Early screening of risk for multidrug-resistant organisms in the emergency department in patients with pneumonia and early septic shock: single-center, retrospective cohort study. Shock. 2021;55(2):198\u2013209. https:\/\/doi.org\/10.1097\/shk.0000000000001599.","journal-title":"Shock"},{"issue":"10","key":"2733_CR40","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmi.2017.02.027","volume":"23","author":"Y Tagashira","year":"2017","unstructured":"Tagashira Y, Sakamoto N, Isogai T, Hikone M, Kosaka A, Chino R, et al. Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study. Clin Microbiol Infect. 2017;23(10):740\u20137. https:\/\/doi.org\/10.1016\/j.cmi.2017.02.027.","journal-title":"Clin Microbiol Infect"},{"key":"2733_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-56","volume":"12","author":"S Micek","year":"2012","unstructured":"Micek S, Johnson MT, Reichley R, Kollef MH. An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis. BMC Infect Dis. 2012;12:56. https:\/\/doi.org\/10.1186\/1471-2334-12-56.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2733_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1590\/s1806-37132012000200002","volume":"38","author":"CD Silveira","year":"2012","unstructured":"Silveira CD, Ferreira CS, Corr\u00eaa RA. Adherence to guidelines and its impact on outcomes in patients hospitalized with community-acquired pneumonia at a university hospital. J Bras Pneumol. 2012;38(2):148\u201357. https:\/\/doi.org\/10.1590\/s1806-37132012000200002.","journal-title":"J Bras Pneumol"},{"issue":"1","key":"2733_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10096-016-2779-5","volume":"36","author":"J Rello","year":"2017","unstructured":"Rello J, Diaz E, Ma\u00f1ez R, Sole-Violan J, Valles J, Vidaur L, et al. Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case-control study. Eur J Clin Microbiol Infect Dis. 2017;36(1):123\u201330. https:\/\/doi.org\/10.1007\/s10096-016-2779-5.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"2733_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106379","volume":"58","author":"V D'Onofrio","year":"2021","unstructured":"D\u2019Onofrio V, Meersman A, Magerman K, Waumans L, van Halem K, Cox JA, et al. Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes. Int J Antimicrob Agents. 2021;58(3):106379. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106379.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"2733_CR45","first-page":"378","volume":"22","author":"Y Wiener-Well","year":"2020","unstructured":"Wiener-Well Y, Hadeedi M, Schwartz Y, Yinnon AM, Munter G. Prospective audit of empirical antibiotic therapy for septic patients. Isr Med Assoc J. 2020;22(6):378\u201383.","journal-title":"Isr Med Assoc J"},{"key":"2733_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-121","volume":"14","author":"ST Nyg\u00e5rd","year":"2014","unstructured":"Nyg\u00e5rd ST, Langeland N, Flaatten HK, Fanebust R, Haugen O, Skrede S. Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital. BMC Infect Dis. 2014;14:121. https:\/\/doi.org\/10.1186\/1471-2334-14-121.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2733_CR47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/0885066616677710","volume":"33","author":"Y Lee","year":"2018","unstructured":"Lee Y, Lee YT, Wang YC, Chen CT, Sun JR, Liu CP, et al. Risk of mortality of catheter-related bloodstream infections caused by Acinetobacter species: is early removal of the catheters associated with a better survival outcome? J Intensive Care Med. 2018;33(6):361\u20139. https:\/\/doi.org\/10.1177\/0885066616677710.","journal-title":"J Intensive Care Med"},{"issue":"7","key":"2733_CR48","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/j.1469-0691.2010.03394.x","volume":"17","author":"M Suppli","year":"2011","unstructured":"Suppli M, Aabenhus R, Harboe ZB, Andersen LP, Tvede M, Jensen JU. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy. Clin Microbiol Infect. 2011;17(7):1078\u201383. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03394.x.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"2733_CR49","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1469-0691.2010.03314.x","volume":"17","author":"N Fern\u00e1ndez-Hidalgo","year":"2011","unstructured":"Fern\u00e1ndez-Hidalgo N, Almirante B, Tornos P, Gonz\u00e1lez-Alujas MT, Planes AM, Larrosa MN, et al. Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital--prospective analysis of referral bias and influence of inadequate antimicrobial treatment. Clin Microbiol Infect. 2011;17(5):769\u201375. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03314.x.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"2733_CR50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1590\/s1020-49892012001100004","volume":"32","author":"JS Castillo","year":"2012","unstructured":"Castillo JS, Leal AL, Cortes JA, Alvarez CA, Sanchez R, Buitrago G, et al. Mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia: a multicenter cohort study in Colombia. Rev Panam Salud Publica. 2012;32(5):343\u201350. https:\/\/doi.org\/10.1590\/s1020-49892012001100004.","journal-title":"Rev Panam Salud Publica"},{"issue":"7","key":"2733_CR51","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1469-0691.2012.03988.x","volume":"19","author":"YT Lee","year":"2013","unstructured":"Lee YT, Kuo SC, Yang SP, Lin YT, Chiang DH, Tseng FC, et al. Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities? Clin Microbiol Infect. 2013;19(7):640\u20135. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03988.x.","journal-title":"Clin Microbiol Infect"},{"key":"2733_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-311","volume":"13","author":"YS Yang","year":"2013","unstructured":"Yang YS, Lee YT, Tsai WC, Kuo SC, Sun JR, Yang CH, et al. Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis. BMC Infect Dis. 2013;13:311. https:\/\/doi.org\/10.1186\/1471-2334-13-311.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2733_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010153","volume":"9","author":"YC Wang","year":"2020","unstructured":"Wang YC, Ku WW, Yang YS, Kao CC, Kang FY, Kuo SC, et al. Is polymicrobial bacteremia an independent risk factor for mortality in Acinetobacter baumannii bacteremia? J Clin Med. 2020;9(1):10. https:\/\/doi.org\/10.3390\/jcm9010153.","journal-title":"J Clin Med"},{"issue":"5","key":"2733_CR54","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.ajem.2019.158359","volume":"38","author":"CH Lee","year":"2020","unstructured":"Lee CH, Yang CY, Hsieh CC, Hong MY, Lee CC. Differential impacts of inappropriate empirical therapy on ED patients with Staphylococcus aureus and streptococci bacteremia. Am J Emerg Med. 2020;38(5):940\u20136. https:\/\/doi.org\/10.1016\/j.ajem.2019.158359.","journal-title":"Am J Emerg Med"},{"issue":"1","key":"2733_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00824-4","volume":"9","author":"FY Kang","year":"2020","unstructured":"Kang FY, How CK, Wang YC, Cheng A, Yang YS, Kuo SC, et al. Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia. Antimicrob Resist Infect Control. 2020;9(1):160. https:\/\/doi.org\/10.1186\/s13756-020-00824-4.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"2733_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jac\/dkw402","volume":"72","author":"SE Battle","year":"2017","unstructured":"Battle SE, Bookstaver PB, Justo JA, Kohn J, Albrecht H, Al-Hasan MN. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017;72(1):299\u2013304. https:\/\/doi.org\/10.1093\/jac\/dkw402.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2733_CR57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40121-017-0179-5","volume":"7","author":"KC Claeys","year":"2018","unstructured":"Claeys KC, Zasowski EJ, Trinh TD, Lagnf AM, Davis SL, Rybak MJ. Antimicrobial stewardship opportunities in critically ill patients with Gram-negative lower respiratory tract infections: a multicenter cross-sectional analysis. Infect Dis Ther. 2018;7(1):135\u201346. https:\/\/doi.org\/10.1007\/s40121-017-0179-5.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"2733_CR58","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.49353","volume":"6","author":"T Ohnuma","year":"2023","unstructured":"Ohnuma T, Chihara S, Costin B, Treggiari MM, Bartz RR, Raghunathan K, et al. Association of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the US. JAMA Netw Open. 2023;6(1):e2249353. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.49353.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2733_CR59","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/cid\/ciac727","volume":"76","author":"J Van Heuverswyn","year":"2023","unstructured":"Van Heuverswyn J, Valik JK, van der Desir\u00e9e Werff S, Hedberg P, Giske C, Naucl\u00e9r P. Association between time to appropriate antimicrobial treatment and 30-day mortality in patients with bloodstream infections: a retrospective cohort study. Clin Infect Dis. 2023;76(3):469\u201378. https:\/\/doi.org\/10.1093\/cid\/ciac727.","journal-title":"Clin Infect Dis"},{"key":"2733_CR60","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.2147\/idr.S402172","volume":"16","author":"Y Luo","year":"2023","unstructured":"Luo Y, Guo Z, Li Y, Ouyang H, Huang S, Chen Y, et al. Appropriateness of empirical antibiotic therapy in hospitalized patients with bacterial infection: a retrospective cohort study. Infect Drug Resist. 2023;16:4555\u201368. https:\/\/doi.org\/10.2147\/idr.S402172.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"2733_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08329-2","volume":"23","author":"S Xu","year":"2023","unstructured":"Xu S, Song Z, Han F, Zhang C. Effect of appropriate empirical antimicrobial therapy on mortality of patients with Gram-negative bloodstream infections: a retrospective cohort study. BMC Infect Dis. 2023;23(1):344. https:\/\/doi.org\/10.1186\/s12879-023-08329-2.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"2733_CR62","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00674-23","volume":"11","author":"M Chumbita","year":"2023","unstructured":"Chumbita M, Puerta-Alcalde P, Y\u00e1\u00f1ez L, Angeles Cuesta M, Chinea A, Espa\u00f1ol-Morales I, et al. High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations. Microbiol Spectr. 2023;11(4):e0067423. https:\/\/doi.org\/10.1128\/spectrum.00674-23.","journal-title":"Microbiol Spectr"},{"key":"2733_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1137811","volume":"14","author":"Q Yuan","year":"2023","unstructured":"Yuan Q, Guo L, Li B, Zhang S, Feng H, Zhang Y, et al. Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study. Front Microbiol. 2023;14:1137811. https:\/\/doi.org\/10.3389\/fmicb.2023.1137811.","journal-title":"Front Microbiol"},{"issue":"1","key":"2733_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s15010-023-02073-0","volume":"52","author":"A Roseau-Vincenti","year":"2024","unstructured":"Roseau-Vincenti A, Forestier E, Lanoix JP, Ricard C, Carret MC, Caraux-Paz P, et al. Empirical antibiotic therapy modalities for Enterobacteriaceae bloodstream infections in older patients and their impact on mortality: a multicentre retrospective study. Infection. 2024;52(1):155\u201363. https:\/\/doi.org\/10.1007\/s15010-023-02073-0.","journal-title":"Infection"},{"key":"2733_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13070601","author":"V Zerbato","year":"2024","unstructured":"Zerbato V, Pol R, Sanson G, Suru DA, Pin E, Tabolli V, et al. Risk factors for 30-day mortality in nosocomial enterococcal bloodstream infections. Antibiotics. 2024. https:\/\/doi.org\/10.3390\/antibiotics13070601.","journal-title":"Antibiotics"},{"key":"2733_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1294141","volume":"11","author":"S Xiao","year":"2023","unstructured":"Xiao S, Liang X, Han L, Zhao S. Incidence, antimicrobial resistance and mortality of Pseudomonas aeruginosa bloodstream infections among hospitalized patients in China: a retrospective observational multicenter cohort study from 2017 to 2021. Front Public Health. 2023;11:1294141. https:\/\/doi.org\/10.3389\/fpubh.2023.1294141.","journal-title":"Front Public Health"},{"issue":"12","key":"2733_CR67","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.cmi.2024.09.011","volume":"30","author":"A Loiodice","year":"2024","unstructured":"Loiodice A, Bailly S, Ruckly S, Buetti N, Barbier F, Staiquly Q, et al. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study. Clin Microbiol Infect. 2024;30(12):1559\u201368. https:\/\/doi.org\/10.1016\/j.cmi.2024.09.011.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2733_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09700-7","volume":"24","author":"T Riccobene","year":"2024","unstructured":"Riccobene T, Ye G, Lock J, Yu KC, Ai C, Gregory S, et al. Outcomes of inadequate empiric therapy and timing of newer antibacterial therapy in hospitalized adults with culture-positive Enterobacterales and Pseudomonas aeruginosa: a multicenter analysis. BMC Infect Dis. 2024;24(1):810. https:\/\/doi.org\/10.1186\/s12879-024-09700-7.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2733_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107630","volume":"66","author":"B Pilmis","year":"2025","unstructured":"Pilmis B, Dortet L. Epidemiology, treatment and outcomes of bloodstream infections due to MBL-producing Enterobacterales in France: a retrospective study. Int J Antimicrob Agents. 2025;66(6):107630. https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107630.","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"2733_CR70","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/jac\/dkaf242","volume":"80","author":"M Del Monte","year":"2025","unstructured":"Del Monte M, Kaleci S, Chester J, Zerbato V, Remitti M, Tili A, et al. Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study. J Antimicrob Chemother. 2025;80(9):2466\u201373. https:\/\/doi.org\/10.1093\/jac\/dkaf242.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"2733_CR71","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1093\/jac\/dkaf197","volume":"80","author":"M Rinaldi","year":"2025","unstructured":"Rinaldi M, Rancan I, Malerba F, Gatti M, Ancillotti L, Tazza B, et al. Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes. J Antimicrob Chemother. 2025;80(8):2247\u201356. https:\/\/doi.org\/10.1093\/jac\/dkaf197.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2733_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317540","volume":"20","author":"S Corcione","year":"2025","unstructured":"Corcione S, Mornese Pinna S, Vena A, Schenone M, Sanino M, Pascale R, et al. Pseudomonas aeruginosa bloodstream infections in internal medicine wards: a large Italian multicenter retrospective study. PLoS ONE. 2025;20(5):e0317540. https:\/\/doi.org\/10.1371\/journal.pone.0317540.","journal-title":"PLoS ONE"},{"issue":"1","key":"2733_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11010-5","volume":"25","author":"R Itani","year":"2025","unstructured":"Itani R, Khojah HMJ, Raychouni H, Kibrit R, Shuhaiber P, Dib C, et al. Management practices and mortality predictors among Klebsiella pneumoniae infections across Lebanese hospitals: a multicenter retrospective study. BMC Infect Dis. 2025;25(1):620. https:\/\/doi.org\/10.1186\/s12879-025-11010-5.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"2733_CR74","doi-asserted-by":"publisher","first-page":"e1066","DOI":"10.1097\/ccm.0000000000006606","volume":"53","author":"F Barbier","year":"2025","unstructured":"Barbier F, Buetti N, Dupuis C, Schwebel C, Azoulay \u00c9, Argaud L, et al. Prognostic impact of early appropriate antimicrobial therapy in critically ill patients with nosocomial pneumonia due to gram-negative pathogens: a multicenter cohort study. Crit Care Med. 2025;53(5):e1066\u201379. https:\/\/doi.org\/10.1097\/ccm.0000000000006606.","journal-title":"Crit Care Med"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02733-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02733-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02733-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:50:24Z","timestamp":1782921024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02733-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2733"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02733-x","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"PRISMA checklist in the appendix.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Standards of reporting"}}]}}